Patriot Scientific der Highflyer 2006
http://www.medical-tribune.at/...dssid=4170&dsmid=62042&dspaid=465958
(Hab nur den Link reingestellt, sonst werde ich noch wegen Board-Verschmutzung belangt.
Grüße Abenteurer
Unfortunately this was scanned in Adobe file format. If you would like to see this file e-mail me at wolfpackvoltare@aol.com and I will send it to you.
wolfpackvolt
Es ist die Erwiderung auf die Vorwürfe von Fish (Ankläger) gegen PTSC (Beklagter= defendant).
Da ich glaube, daß wolfpack ein Anwalt ist, müßte man halt ihn fragen.
probiers mal hier mit dem upload für die pdf: http://uploadyourfiles.de/
wenns klappt kannst ja den link dann hier ins forum stellen ...
habs eben mit einer 1,4 MB pdf getestet ... funktioniert
"We love to entertain you"
Optionen
| Boardmail an "GL1800" |
Wertpapier: Patriot Scientific |
http://sv1.uploadyourfiles.de/file/ydtg83j776x6/...nt%20by%20PTSC.pdf
Gruss Killercop
Gruß Neureich
;)
.......................................
That’s it... let’s make some money now!
Optionen
| Boardmail an "ostseebrise." |
Wertpapier: Patriot Scientific |
Angehängte Grafik:
sc.png (verkleinert auf 82%)
sc.png (verkleinert auf 82%)
Was nicht ist kann ja noch werden .................
Dutton Associates Announces Investment Opinion: Patriot Scientific Coverage Initiated with Speculative Buy Rating By Dutton Associates
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--
Dutton Associates initiates its coverage of Patriot Scientific Corporation (OTCBB:PTSC) with a Speculative Buy rating and a 12-month price target of $1.06. The 21-page report by Dutton Associates senior analyst Richard W. West, CFA is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, and Knobias and other leading financial portals. Patriot Scientific has begun to execute its new strategy to become a dedicated Intellectual Property company by licensing its portfolio of microprocessor patents and has already granted licenses to 11 major microprocessor manufacturers. Patriot Scientific's portfolio of microprocessor patents runs until 2015.
About Dutton Associates
Dutton Associates is one of the largest independent investment research firms in the U.S. Its 28 senior analysts are primarily CFAs and have expertise in many industries. Dutton Associates provides continuing analyst coverage of 140 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors.
The current cost of enrollment in our one-year continuing research program is US $39,500 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. Dutton Associates received $35,000 from the Company for 4 Research Reports with coverage commencing on 11/27/06. The Firm does not accept any equity compensation. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing.
Source: Patriot Scientific Corporation
http://www.nasdaq.com/asp/...49%2Ehtm&cdtime=11%2F27%2F2006+12%3A00PM
Agilent Technologies Becomes Tenth Major Manufacturer to Purchase Moore Microprocessor Patent™ Portfolio License During 2006
MMP Portfolio licensing program continues to focus on system manufacturing leaders
CUPERTINO, Calif. – Nov. 27, 2006 – Alliacense today announced that Agilent Technologies has purchased from The TPL Group a license to use the Moore Microprocessor Patent™ (MMP) Portfolio. As the tenth company to purchase an MMP Portfolio license this year, Agilent Technologies is preceded by HP, Casio, Fujitsu, Sony, Nikon, Seiko Epson, Pentax, Olympus and Kenwood.
“The global technology leaders that have purchased MMP Portfolio licenses this year recognize the competitive edge to be gained by licensing MMP technologies sooner rather than later,” said Mike Davis, Alliacense Sr. Vice President, Licensing. “As we welcome Agilent Technologies to our distinguished roster of MMP licensees, we also want to encourage all electronic product manufacturers to contact us regarding the significant competitive advantages of becoming an early MMP Portfolio licensee.”
According to Davis, Agilent Technologies has captured one of the “first-mover” MMP Portfolio licensing berths, which encompass Electronic Measurement, Bioanalytical Measurement, and Semiconductor Test Solutions products. Agilent Technologies is the world’s premier measurement company providing core analytical and electrical instruments to the life sciences, chemical analysis, communications, and electronics industries. The company has two primary businesses: Bio-Analytical Measurement and Electronic Measurement. The company currently has approximately 20,000 employees and serves customers in more than 110 countries. Agilent had revenue of $5.1B in fiscal year 2005.
The MMP Portfolio patents, filed by The TPL Group in the 1980s, cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment -- and automobiles which today have dozens of microprocessor-based key features and benefits.
About the MMP Portfolio
Named after legendary inventor Charles "Chuck" Moore, the MMP Portfolio includes seven US patents as well as their European and Japanese counterparts fundamental to the design of modern microprocessors, microcontrollers and system-on-chip devices. Developed in a joint venture between the TPL Group and Moore, the MMP Portfolio today is jointly owned by privately held TPL Group and publicly held Patriot Scientific Corporation (PTSC.OB).
About Alliacense
Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of intellectual property licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development /management executives, Alliacense focuses on expanding the awareness and value of TPL’s intellectual property portfolios. For more information, visit www.alliacense.com.
Alliacense and Moore Microprocessor Patent (MMP) are trademarks of Technology Properties Limited (TPL). All other trademarks belong to their respective owners.
Growth Strategy Continues As 10th Major Manufacturer Purchases Moore Microprocessor Patent(TM) Portfolio License During 2006
CARLSBAD, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Patriot Scientific Corporation (OTC Bulletin Board: PTSC) confirmed today that Agilent Technologies has become the 10th major manufacturer to purchase a license to use the Moore Microprocessor Patent(TM) (MMP) Portfolio this year. Patriot Scientific and The TPL Group are co-owners of the MMP Portfolio, which Alliacense(TM), a TPL Group enterprise, exclusively manages. In addition to Agilent Technologies, license agreements have been signed in 2006 with HP, Casio, Fujitsu, Sony, Nikon, Seiko Epson, Pentax, Olympus and Kenwood. Earlier agreements were signed with AMD and Intel.
"The sound growth strategy for Patriot Scientific continues to move forward with the signing of each license agreement," said David Pohl, Patriot Scientific chairman and CEO. "Our strategy is two-fold. While the Alliacense team is actively engaging in communications with manufacturers who are candidates to become licensees of our patented technology, the management and board of Patriot Scientific are actively evaluating opportunities to create or acquire other revenue sources that would be in addition to what the company is realizing from our valuable patent portfolio."
Pohl noted that preliminary discussions are currently being held with several companies that are candidates for Patriot Scientific to possibly either acquire the companies or their technologies, or to enter into joint ventures related to existing or new technologies.
"The global technology leaders that have purchased MMP Portfolio licenses this year recognize the competitive edge to be gained by licensing MMP technologies sooner rather than later," said Alliacense Sr. Vice President, Licensing Mike Davis. "As we welcome Agilent Technologies to our distinguished roster of MMP licensees, we also want to encourage all electronic product manufacturers to contact us regarding the significant competitive advantages of becoming an early MMP Portfolio licensee."
According to Davis, Agilent Technologies has captured one of the "first- mover" MMP Portfolio licensing berths, which encompass electronic measurement, bio-analytical measurement and semiconductor test solutions products. Agilent Technologies is the world's premier measurement company providing core analytical and electrical instruments to the life sciences, chemical analysis, communications and electronics industries. The company has two primary businesses: bio-analytical measurement and electronic measurement. The company currently has approximately 20,000 employees and serves customers in more than 110 countries. Agilent had revenue of $5.1 billion in fiscal year 2005.
The MMP Portfolio patents, filed in the 1980s, cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment and automobiles, which today have dozens of microprocessor-based key features and benefits.
About Patriot Scientific
Patriot Scientific is a leading intellectual property licensing company that develops, markets and enables innovative technologies to address the demands in fast-growing markets such as wireless devices, smart cards, home appliances and gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices and industrial controllers. Headquartered in Carlsbad, Calif., information about the company can be found at http://www.ptsc.com.
Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/ptscprofile.aspx.
About the Patent Portfolio
The patent portfolio, marketed as the Moore Microprocessor Patent(TM) Portfolio, contains intellectual property that is jointly owned by the publicly held Patriot Scientific Corporation and the privately held TPL Group. The portfolio encompasses seven U.S. patents as well as their European and Japanese counterparts. Both TPL and Patriot assert that their jointly owned patents protect techniques used in designing microprocessors, microcontrollers, Digital Signal Processors (DSPs), embedded processors and System-on-Chip (SoC) implementations. The MMP Portfolio is exclusively managed by Alliacense, a TPL Group Enterprise.
About Alliacense
Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of intellectual property licensing programs. As a cadre of IP licensing strategists, technology experts and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL's intellectual property portfolios. For more information, visit http://www.alliacense.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Moore Microprocessor Patent, MMP and Alliacense are trademarks of Technology Properties Limited (TPL). PTSC is a trademark of Patriot Scientific Corporation. All other trademarks belong to their respective owners.
CONTACTS:
Patriot Media Relations
The Hoffman Agency
David Friedman
(303) 868-9641
dfriedman@hoffman.com
Patriot Investor Relations
Hawk Associates
Frank Hawkins or Ken AuYeung
(305) 451-1888
info@hawkassociates.com
Alliacense Media Relations
TPL Group
Tom Rigoli
(650) 969-5986
rigoli@mindpik.com
SOURCE Patriot Scientific Corporation
Allerdings ist ja Schönreden die Stärke eines jeden Analysten bzw. hier:
"Patriot Media Relations"
Und...Was bzw. Wer steckt hinter den "Patriot Investor Relations"
immerhin hats für ein paar PRozente Ausschlag (nach oben) gereicht.
enjoy
esistjazz
http://www.hawkassociates.com
Hawk Associates ist die Firma die Anfragen von Aktionären beantwortet. Ein Service für kleine Firmen, die sich von der Anfragen-Flut überfordert fühlen. Vergleichbar mit einer PR-Agentur, die sich um PR-Belange kümmert.
Noch meine Einschätzung: Es ist ruhig um unser Baby geworden, aber es wird fleißig hinter den Kulissen weiterverhandelt. Sicher noch keine Zeit um Kasse zu machen, aber dir Richtung stimmt. Nachkaufen kann man zu diesen Kursen alle mal: Ich hatte vor einiger Zeit noch ein Packet für 1.05 USD erworben, und obwohl da jetzt ein Lücke von 40 Prozent klafft, bereitet mir das keine Kopfschmerzen. 1.05 wird mir irgendwann sicher wieder billig vorkommen.
Grüße Abenteurer
Verstehe gar nicht die Euphorie nach dem Report. M.E. ist der Report doch wenig positiv:
1. Kursziel: 1.06 USD. Klar, wäre schön, mal wieder den Dollar zu sehen. Aber wurden hier nicht immer Ziele von 5-10 USD genannt?
Und Dutton hat bei dem Kursziel 200 Abschlüsse durch Lizenznehmer unterstellt. Das ist aber wohl noch einiges hin...
2. "Speculative Buy" klingt zunächst gut. Von 6 Kategorien ist das bei Dutton aber die drittschlechteste!
Naja, zumindest ist der Report recht objektiv geschrieben und hat die bestehenden Risiken angeführt (wenngleich das Fish-Risiko m.E. etwas zu milde dargestellt wurde). Ob hierdurch jedoch neue Anleger gewonnen werden können, wage ich zu bezweifeln.
Der Report ist mir relativ schnuppe. (Hab ihn noch nicht mal gelesen.) Ich bin auch nicht euphorisch, sondern kalkuliere das Risiko einer Anlage nach den Zukunftsaussichten und den Tatsachen. Von Kurszielen halte ich nichts, auch nicht von meinen eigenen, denn wenn Du mal weiter vorne liest, wirst Du feststellen, wie sehr ich mich geirrt habe.
So wie Du schreibst, wird der Report nur marginalen Einfluß auf die Kaufentscheidung von Anlegern haben. Was mich aber positiv stimmt, ist die allgemeine Entwicklung der Märkte, die spezielle Entwicklung bei PTSC und die absehbare Gerichtsentscheidung in Texas. Ohne Zweifel negativ muss man die Fish-Klage betrachten. Für mich aber weiterhin ein ausgeglichenes Chance - Risiko Verhältnis.
Grüße Abenteurer
Andererseits sind das in meinen Augen gerade mal 200 Lizenznehmer. Es wird bei Patriot aber von 500 Firmen gesprochen, die Patentverletzer sind. Lediglich 300 wurden bisher angeschrieben. Auch ist
die gerichtliche Entscheidung in Texas ebenfalls (logischerweise)
nicht mit berücksichtigt(Was ein positiver Ausgang zusätzlich für den Kurs bedeutet ist ja wohl klar).
Da an der Börse aber die Zukunft von großer Bedeutung ist (oftmals auch vorweggenommen wird), bin ich persönlich weiterhin sehr zuversichtlich.
Gruß,Salo
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=000…
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=000…